Antegrade (AERPAP) and retrograde (RERPAP) effective refractory periods of the accessory pathway were measured at multiple cycle lengths in 47 patients with the Wolff-Parkinson-White syndrome. In 20 patients the effect of changing cycle length on AERPAP could be determined. In 12 patients AERPAP decreased by 10-45 msec, in six it increased by 10-35 msec, and in two it was unchanged. In 13 of 15 patients in whom the effect of decreasing cycle length on RERPAP could be assessed, RERPAP decreased by 10-60 msec. In eight patients, the shortest AERPAP correlated well (r = 0.83) with the shortest R-R interval of consecutive pre-excited beats in atrial fibrillation. However, predominantly normal conduction was observed in six of 28 patients with atrial fibrillation, probably because of concealment in the bypass. Therefore, induction of atrial fibrillation during electrophysiological evaluation may provide additional information. The RERPAP at the cycle length of the arrhythmia was shorter than the cycle length of reciprocating tachycardia in all but one of 21 patients. At the same or comparable cycle lengths, AERPAP was usually greater than RERPAP.
THE USE OF TECHNIQUES for intracardiac
stimulation and recording has advanced our understanding of the electrophysiological mechanisms which underlie the Wolff-Parkinson-White syndrome. These mechanisms have been discussed in recent reviews.1-7 It has been established that in the classic reciprocating tachycardia associated with the syndrome, circus movement is maintained by retrograde conduction over the accessory pathway (AP) with antegrade conduction over the His-Purkinje system. In a minority of cases, conduction may proceed over the circuit in the reverse direction. In atrial flutter or fibrillation the AP usually sustains antegrade conduction for most or all propagated beats and the resulting ventricular rate is determined by the properties of conduction and refractoriness of the AP. These properties of the AP during antegrade and retrograde conduction have been studied and compared in relatively few patients.5 1'4 The purpose of the present study was to examine the antegrade (AERPAP) and retrograde (RERPAP) effective refractory periods of the AP in a large group of patients with WolffParkinson-White syndrome. The effect of alterations of basic cycle length upon AERPAP and RERPAP was determined and an attempt was made to relate refractory periods measured during regular cardiac pacing to the ventricular rate observed during atrial fibrillation and reciprocating tachycardia.
Materials and Methods
Forty-seven consecutive patients (34 M/13 F) with WolffParkinson-White syndrome were studied. Their ages ranged from nine to 71 years. All patients presented with recurrent tachyarrhythmias, some of which were life-threatening. Most were referred as potential candidates for surgical division of the AP. Subsequent electrophysiological evaluation suggested that 18 patients had APs between the left atrium and ventricle, 12 had APs between the right atrium and ventricle, and in 18 the AP was thought to connect septal structures. In three of the patients, there was unidirectional antegrade block in the AP, and electrocardiographic and electrophysiological evidence of ventricular pre-excitation was not apparent. However, the AP sustained retrograde conduction in reciprocating tachycardia. Two patients had dual APs. In one, both APs were left-sided. The other patient had a right lateral and a left lateral AP. Surgery was performed in 23 of these 47 patients, confirming the suspected location of the AP. A full discussion of these patients has been presented with an account of the total experience of this institution. '5 The nature of the procedure was fully explained to all patients and informed consent was obtained. In all except two patients, antiarrhythmic therapy was discontinued 48 hours prior to the time of study. Two patients were main-tained on oral procainamide to control their extremely rapid ventricular rate in atrial fibrillation. Reciprocating tachycardia was initiated by this method in all except six patients. The site of earliest retrograde atrial activation during tachycardia was used to help localize the AP. Refractory periods were measured at several basic cycle lengths (A,A, or V,V1) in most patients using stimulating and recording sites close to the location of the AP.'6 The AERPAP was defined as the longest A,A2 interval near the AP which failed to conduct with pre-excitation. The RERPAP was defined as the longest V,V2 interval near the AP which failed to conduct over it. The observations used to detect retrograde conduction over the AP have been described elsewhere. '2' 16 Atrial fibrillation occurred spontaneously or was induced by right atrial pacing at a cycle length of 150-200 msec in 28 of the 47 patients. For the correlation between AERPAP and the shortest ventricular cycle length observed in atrial fibrillation, the shortest interval between two successive preexcited beats was measured.
Results
Antegrade Properties of Accessory Pathway
Effect of cycle length on AERPAP. Thirty-nine patients had AERPAP estimated (table 1). Its exact measurement was possible at all cycle lengths studied in only 21 of these patients. In four of the 18 patients in whom precise determination was limited by the effective refractory period (ERP) of the atrium at some or all cycle lengths, the site of atrial stimulation was important. In these four, atrial ERP was reached prior to AERPAP at some sites, but not others."' The Designed by Michael Feezor, Ph.D., and built by Phil Talbert, Duke University. predominance of normally conducted beats during the determinations. Therefore, AERPAP was probably long in these two patients also. For the eight patients in whom the AERPAP could be measured exactly, there was a significant correlation between the shortest ventricular cycle length of two consecutive pre-excited beats in atrial fibrillation and the shortest AERPAP observed at any cycle length (r = 0.83) ( fig.  3 ). When the additional ten patients in whom AERPAP could not be measured exactly because of a longer atrial ERP were included, the correlation between AERPAP and the shortest ventricular cycle length of two consecutive pre-excited beats was considerably weakened (r = 0.31). the 36 patients in whom retrograde refractory periods were measured had a RERPAP greater than the ventricular ERP and conducted retrogradely over their bypass during circus movement tachycardia (a patient the location of whose AP supported antegrade conduction during reciprocating tachycardia was excluded from this present correlation between RERPAP and tachycardia cycle length). In the 21 patients, the cycle length of the tachycardia correlated weakly (r = 0.44) with RERPAP determined at the closest basic cycle length to that of the arrhythmia ( fig. 5 ). However, this cycle length at which refractoriness was determined averaged 107 msec greater than the cycle length of the tachycardia. The correlation coefficient was 0.55 when a further 10 patients in whom RERPAP was less than or equal to ventricular ERP were considered ( fig. 5 ). The reason for this strengthening of the correlation is not completely apparent (see Discussion). The RERPAP was greater than the cycle length of reciprocating tachycardia in only one of these 31 patients.
Comparison of Antegrade and Retrograde Refractoriness
In 13 patients in whom neither AERPAP nor RERPAP were limited by atrial or ventricular ERP, antegrade and retrograde refractoriness could be compared at the same cycle length on 12 occasions and at similar cycle length (within 50-100 msec) on six occasions ( fig. 6 ). The AERPAP and RERPAP were the same in six determinations, AERPAP was longer (range 10-215 msec) in ten determinations and shorter (by 10 msec and 50 msec) than RERPAP in two determinations. There was no significant correlation between AERPAP and RERPAP.
In another ten patients in whom AERPAP was measured exactly, but RERPAP was limited by ventricular refractoriness, the AERPAP was at least 10 msec longer than the RERPAP determined at the same cycle length in 15 of 16 determinations. In all 11 estimations of RERPAP in another five patients in whom RERPAP was measured exactly but AERPAP was limited by atrial refractoriness, RERPAP at the same cycle length was at least 10 msec longer. Therefore, AERPAP was more often longer (22 occasions) than the same (11 occasions) or shorter (12 occasions) than RERPAP. This tendency for RERPAP to 24 In this study, AERPAP typically decreased as cycle length shortened. The definite lengthening of AERPAP with shorter cycle lengths in one patient was confirmed in separate studies on successive days. This patient also exhibited unidirectional retrograde block in the AP and reciprocating tachycardia could not be induced. The AP in this patient may have differed morphologically from the other APs. 25 The maximum decrease in AERPAP in any patient in this series over the cycle lengths studied was only 45 msec, which agrees closely with the findings of Wellens and 600[ 21 .5%) of conduction solely over the normal pathway during atrial fibrillation in patients who show ventricular pre-excitation during sinus rhythm. This discrepancy is most probably due to concealed conduction, which has been well described in AP.' 1`The AERPAP was usually long in these patients, and at faster rates without pre-excited ventricular beats, propagation over the normal conduction pathway was probably followed by retrograde penetration of the AP, thus tending to perpetuate normal conduction. In this situation, the ventricular rate during atrial fibrillation is limited by antegrade refractoriness of the atrioventricular node rather than of the AP. It has not been fully determined whether concealment is a consistent phenomenon. Our present experience suggests that, at least in some patients, it is not constant. Continuous electrocardiographic monitoring of one patient showed that although atrial fibrillation was associated with a normal ventricular conduction pattern during almost all of a 24 hour period, runs of rapid preexcited beats occasionally occurred. Concealment may occur during atrial fibrillation, but not be evident when there is a slower atrial mechanism, as in atrial flutter ( fig. 7) .
For circus movement tachycardia to utilize the AP for retrograde conduction, it would appear necessary that the RERPAP (at the cycle length of the arrhythmia) be less than the cycle length of the tachycardia. In most of our patients, RERPAP was determined at cycle lengths greater than this. Since RERPAP is cycle length dependent, this would lead to a spuriously high estimate of the RERPAP which would obtain during tachycardia. Despite this, there was only one patient in whom the RERPAP was not less than the cycle length of spontaneous reciprocating tachycardia. It is not completely apparent to us why RERPAP should correlate with the cycle length of the arrhythmia. The cycle length should depend upon antegrade conduction time over the normal conduction system, intraventricular conduction time to the point of entrance into the AP, retrograde conduction time over the AP and intra-atrial conduction time from the point at which the impulse leaves the AP to its entry into the A-V node. Some correlation between the cycle length of the tachycardia and RERPAP would be expected if the AP is always that part of the circuit whose refractoriness limits full speed conduction. However, this has not been proven. 
